Medpace Holdings, Inc. (MEDP) Is At $38.02 Formed Wedge; MFS High Income Municipal Trust (CXE)’s Sentiment Is 0.9

Medpace Holdings, Inc. (MEDP) formed wedge up with $40.68 target or 7.00% above today’s $38.02 share price. Medpace Holdings, Inc. (MEDP) has $1.35B valuation. The stock decreased 0.03% or $0.01 during the last trading session, reaching $38.02. About 2,167 shares traded. Medpace Holdings, Inc. (NASDAQ:MEDP) has 0.00% since February 20, 2017 and is . It has underperformed by 16.70% the S&P500.

The stock increased 0.60% or $0.03 during the last trading session, reaching $4.99. About 10,430 shares traded. MFS High Income Municipal Trust (CXE) has declined 3.58% since February 20, 2017 and is downtrending. It has underperformed by 20.28% the S&P500.

Horizon Kinetics Llc holds 0.09% of its portfolio in MFS High Income Municipal Trust for 559,361 shares. Mackay Shields Llc owns 303,705 shares or 0.06% of their US portfolio. Moreover, Robinson Capital Management Llc has 0.06% invested in the company for 24,179 shares. The Colorado-based Advisors Asset Management Inc. has invested 0.02% in the stock. Laurion Capital Management Lp, a New York-based fund reported 307,684 shares.

Analysts await Medpace Holdings, Inc. (NASDAQ:MEDP) to report earnings on February, 26. They expect $0.38 earnings per share, up 8.57% or $0.03 from last year’s $0.35 per share. MEDP’s profit will be $13.46M for 25.01 P/E if the $0.38 EPS becomes a reality. After $0.40 actual earnings per share reported by Medpace Holdings, Inc. for the previous quarter, Wall Street now forecasts -5.00% negative EPS growth.

Among 5 analysts covering Medpace Holdings Inc. – Common Stock (NASDAQ:MEDP), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Medpace Holdings Inc. – Common Stock has $35 highest and $32.50 lowest target. $34.38’s average target is -9.57% below currents $38.02 stock price. Medpace Holdings Inc. – Common Stock had 5 analyst reports since September 6, 2016 according to SRatingsIntel. The stock of Medpace Holdings, Inc. (NASDAQ:MEDP) has “Outperform” rating given on Tuesday, September 6 by Credit Suisse. The stock of Medpace Holdings, Inc. (NASDAQ:MEDP) earned “Neutral” rating by Robert W. Baird on Tuesday, September 6. The firm earned “Buy” rating on Tuesday, September 6 by UBS. The rating was initiated by Wells Fargo with “Outperform” on Tuesday, September 6. Jefferies initiated Medpace Holdings, Inc. (NASDAQ:MEDP) on Tuesday, September 6 with “Hold” rating.